Present and future evolution of advanced breast cancer therapy

Por Álvarez, Ricardo H
Publicado em 2010

Handbook of her2-targeted agents in breast cancer

Por Alvarez, Ricardo H.
Publicado em c201

Dual human epidermal growth factor receptor 2 blockade for the treatment of HER2-positive breast cancer

Por Alvarez, Ricardo H., Hortobagyi, Gabriel N.
Publicado em 2013

Locoregional Interaction of Ixabepilone (Ixempra) After Breast Cancer Radiation

Por Takiar, Vinita, Strom, Eric A., Baumann, Donald P., Meric-Bernstam, Funda, Alvarez, Ricardo H., Gonzalez-Angulo, Ana M.
Publicado em 2013

Bevacizumab Treatment for Advanced Breast Cancer

Por Alvarez, Ricardo H., Guarneri, Valentina, Icli, Fikri, Johnston, Stephen, Khayat, David, Loibl, Sibylle, Martin, Miguel, Zielinski, Christoph, Conte, PierFranco, Hortobagyi, Gabriel N.
Publicado em 2011

Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients

Por Niu, Jiaxin, Andres, Grant, Kramer, Kim, Kundranda, Madappa N, Alvarez, Ricardo H, Klimant, Eiko, Parikh, Ankur R, Tan, Bradford, Staren, Edgar D, Markman, Maurie
Publicado no Onco Targets Ther (2015)

Inflammatory Breast Cancer: What We Know and What We Need to Learn

Por Yamauchi, Hideko, Woodward, Wendy A., Valero, Vicente, Alvarez, Ricardo H., Lucci, Anthony, Buchholz, Thomas A., Iwamoto, Takayuki, Krishnamurthy, Savitri, Yang, Wei, Reuben, James M., Hortobágyi, Gabriel N., Ueno, Naoto T.
Publicado em 2012

High HER2/Centromeric Probe for Chromosome 17 Fluorescence In Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant...

Por Kogawa, Takahiro, Fouad, Tamer M., Liu, Diane D., Wu, Jimin, Shen, Yu, Masuda, Hiroko, Fujii, Takeo, Chavez-MacGregor, Mariana, Alvarez, Ricardo H., Hortobágyi, Gabriel N., Valero, Vicente, Ueno, Naoto T.
Publicado no Oncologist (2016)

Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation

Por Takiar, Vinita, Akay, Catherine L, Stauder, Michael C, Tereffe, Welela, Alvarez, Ricardo H, Hoffman, Karen E, Perkins, George H, Strom, Eric A, Buchholz, Thomas A, Ueno, Naoto T, Babiera, Gildy, Woodward, Wendy A
Publicado em 2014

A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer

Por Cristofanilli, Massimo, Johnston, Stephen R. D., Manikhas, Alexey, Gomez, Henry L., Gladkov, Oleg, Shao, Zhimin, Safina, Sufia, Blackwell, Kimberly L., Alvarez, Ricardo H., Rubin, Stephen D., Ranganathan, Sulabha, Redhu, Suman, Trudeau, Maureen E.
Publicado em 2012

Phase I–II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin–cyclophosphamide in HER2/neu-negative inflammatory carcinoma and...

Por Andreopoulou, Eleni, Vigoda, Ivette S., Valero, Vicente, Hershman, Dawn L., Raptis, George, Vahdat, Linda T., Han, Hyo S., Wright, John J., Pellegrino, Christine M., Cristofanilli, Massimo, Alvarez, Ricardo H., Fehn, Karen, Fineberg, Susan, Sparano, Joseph A.
Publicado em 2013

Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer

Por Alexander, Angela, Karakas, Cansu, Chen, Xian, Carey, Jason P.W ., Yi, Min, Bondy, Melissa, Thompson, Patricia, Cheung, Kwok Leung, Ellis, Ian O., Gong, Yun, Krishnamurthy, Savitri, Alvarez, Ricardo H., Ueno, Naoto T., Hunt, Kelly K., Keyomarsi, Khandan
Publicado no Oncotarget (2017)

Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast Cancer

Por Kogawa, Takahiro, Fouad, Tamer M., Wei, Caimiao, Masuda, Hiroko, Kai, Kazuharu, Fujii, Takeo, El-Zein, Randa, Chavez-MacGregor, Mariana, Litton, Jennifer K., Brewster, Abenaa, Alvarez, Ricardo H., Hortobagyi, Gabriel N., Valero, Vicente, Theriault, Richard, Ueno, Naoto T.
Publicado no J Cancer (2015)

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

Por Giuliano, Mario, Giordano, Antonio, Jackson, Summer, Hess, Kenneth R, De Giorgi, Ugo, Mego, Michal, Handy, Beverly C, Ueno, Naoto T, Alvarez, Ricardo H, De Laurentiis, Michelino, De Placido, Sabino, Valero, Vicente, Hortobagyi, Gabriel N, Reuben, James M, Cristofanilli, Massimo
Publicado em 2011

High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2(+) Inflammatory Breast Ca...

Por Anfossi, Simone, Giordano, Antonio, Gao, Hui, Cohen, Evan N., Tin, Sanda, Wu, Qiong, Garza, Raul J., Debeb, Bisrat G., Alvarez, Ricardo H., Valero, Vicente, Hortobagyi, Gabriel N., Calin, George A., Ueno, Naoto T., Woodward, Wendy A., Reuben, James M.
Publicado em 2014

Circulating tumor cells in newly diagnosed inflammatory breast cancer

Por Mego, Michal, Giordano, Antonio, De Giorgi, Ugo, Masuda, Hiroko, Hsu, Limin, Giuliano, Mario, Fouad, Tamer M, Dawood, Shaheenah, Ueno, Naoto T, Valero, Vicente, Andreopoulou, Eleni, Alvarez, Ricardo H, Woodward, Wendy A, Hortobagyi, Gabriel N, Cristofanilli, Massimo, Reuben, James M
Publicado no Breast Cancer Res (2015)

Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination

Por Giuliano, Mario, Giordano, Antonio, Jackson, Summer, De Giorgi, Ugo, Mego, Michal, Cohen, Evan N, Gao, Hui, Anfossi, Simone, Handy, Beverly C, Ueno, Naoto T, Alvarez, Ricardo H, De Placido, Sabino, Valero, Vicente, Hortobagyi, Gabriel N, Reuben, James M, Cristofanilli, Massimo
Publicado no Breast Cancer Res (2014)

Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis

Por Fouad, Tamer M., Kogawa, Takahiro, Liu, Diane D., Shen, Yu, Masuda, Hiroko, El-Zein, Randa, Woodward, Wendy A., Chavez-MacGregor, Mariana, Alvarez, Ricardo H., Arun, Banu, Lucci, Anthony, Krishnamurthy, Savitri, Babiera, Gildy, Buchholz, Thomas A., Valero, Vicente, Ueno, Naoto T.
Publicado no Breast Cancer Res Treat (2015)

A Randomized, Double Blind, Two Period, Placebo-Controlled Crossover Trial of a Sustained-Release Methylphenidate in the Treatment of Fatigue in Cancer Patients

Por Escalante, Carmen P., Meyers, Christina, Reuben, James M., Wang, Xuemei, Qiao, Wei, Manzullo, Ellen, Alvarez, Ricardo H., Morrow, Phuong Khanh, Gonzalez-Angulo, Ana M., Wang, Xin Shelley, Mendoza, Tito, Liu, Wenli, Holmes, Holly, Hwang, Jessica, Pisters, Katherine, Overman, Michael, Cleeland, Charles
Publicado no Cancer J (2014)

Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer

Por Giordano, Antonio, Gao, Hui, Anfossi, Simone, Cohen, Evan, Mego, Michal, Lee, Bang-Ning, Tin, Sanda, De Laurentiis, Michele, Parker, Charla A., Alvarez, Ricardo H., Valero, Vicente, Ueno, Naoto T., De Placido, Sabino, Mani, Sendurai A., Esteva, Francisco J., Cristofanilli, Massimo, Reuben, James M.
Publicado em 2012